Bleakley Financial Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1936953 PARSIPPANY, NJ

Position in GILD

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$3,686,474

-$4,025,146 QoQ

Shares Held

29,179

-47.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#658

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bleakley Financial Group, LLC holds $192,517,114 across 15 Drug Manufacturers - General names. GILD ranks #11 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	45,004	$53,979,152
2	JNJ	Johnson & Johnson	142,327	$36,146,788
3	ABBV	AbbVie Inc.	92,109	$23,178,308
4	MRK	Merck & Co., Inc.	155,898	$20,032,893
5	AMGN	Amgen Inc	38,445	$13,921,703
6	AZN	Astrazeneca PLC	66,437	$12,597,783
7	NVS	Novartis AG	44,930	$7,041,429
8	SNY	Sanofi	159,361	$6,798,340

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,686,474	29,179	-47.3%	Shares	Sole	2026-08-05
2026-03-31	$7,711,620	55,332	+80.3%	Shares	Sole	2026-05-04
2025-12-31	$3,766,031	30,683	+12.8%	Shares	Sole	2026-02-09
2025-09-30	$3,018,090	27,190	-0.9%	Shares	Sole	2025-11-10
2025-06-30	$3,042,716	27,444	-33.0%	Shares	Sole	2025-07-30
2025-03-31	$4,591,696	40,979	+60.8%	Shares	Sole	2025-05-01
2024-12-31	$2,353,957	25,484	+10.5%	Shares	Sole	2025-01-27
2024-09-30	$1,934,188	23,070	+9.2%	Shares	Sole	2024-10-16
2024-06-30	$1,449,249	21,123	-3.5%	Shares	Sole	2024-08-12
2024-03-31	$1,603,515	21,891	+0.0%	Shares	Sole	2024-05-08
2023-12-31	$1,772,579	21,881	+9.3%	Shares	Sole	2024-01-25
2023-09-30	$1,499,699	20,012	-13.7%	Shares	Sole	2023-11-14
2023-06-30	$1,787,176	23,189	-5.9%	Shares	Sole	2023-08-14
2023-03-31	$2,044,380	24,640	-9.0%	Shares	Sole	2023-05-12
2022-12-31	$2,323,701	27,067	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.